Sandra Silberman
Chief Tech/Sci/R&D Officer at MOLECULIN BIOTECH, INC.
Net worth: 53 $ as of 2024-04-29
Sandra Silberman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MOLECULIN BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 2017-11-07 | - |
| CNS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2017-11-30 | - |
Career history of Sandra Silberman
Former positions of Sandra Silberman
| Companies | Position | Start | End |
|---|---|---|---|
| Eisai Medical Research, Inc. | Corporate Officer/Principal | 2003-12-31 | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | 1999-12-31 | - |
| SCORPIUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 2012-12-31 | - |
Training of Sandra Silberman
| Weill Cornell Medical College | Doctorate Degree |
| Zanvyl Krieger School of Arts & Sciences | Undergraduate Degree |
| The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 9 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| SCORPIUS HOLDINGS, INC. | Health Technology |
| MOLECULIN BIOTECH, INC. | Health Technology |
| CNS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
| Eisai Medical Research, Inc. |
- Stock Market
- Insiders
- Sandra Silberman
- Experience
